跳至主要内容
临床试验/EUCTR2005-005534-12-DE
EUCTR2005-005534-12-DE进行中(未招募)不适用

randomized double blind placebo controlled study on the efficacy of autologous autovaccine in house dust mite allergy - FIAVS

The Symbio Herborn Group GmbH0 个研究点目标入组 24 人开始时间: 2005年11月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • otherwise healthy adults with house dust mite allergy prooven by positive prick test and bronchial provocation (FEV1 decrease > 20%). Episodic bronchial asthma (GINA 0-I°). Informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • allergies towards ingredients of the autovaccine. Bronchial asthma > GINA I°, other chronic diseases. Pregnancy.

研究者

发起方
The Symbio Herborn Group GmbH

相似试验